Mizuho Securities Downgrades Quest Diagnostics (DGX) to Neutral
Tweet Send to a Friend
Mizuho Securities downgraded Quest Diagnostics (NYSE: DGX) from Buy to Neutral with a price target of $86.00 (from $84.00) on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
